Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori

Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of clinical nutrition Vol. 80; no. 3; pp. 737 - 741
Main Authors Wang, K.Y, Li, S.N, Liu, C.S, Perng, D.S, Su, Y.C, Wu, D.C, Jan, C.M, Lai, C.H, Wang, T.N, Wang, W.M
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Clinical Nutrition 01.09.2004
American Society for Clinical Nutrition, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.
AbstractList Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans.BACKGROUNDEvidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans.We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth.OBJECTIVEWe administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth.The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the (13)C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation.DESIGNThe in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the (13)C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation.Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001).RESULTSBb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001).Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.CONCLUSIONRegular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.
Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (107 colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans. [PUBLICATION ABSTRACT]
Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.
Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the (13)C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.
Author Li, S.N
Su, Y.C
Jan, C.M
Liu, C.S
Wu, D.C
Perng, D.S
Lai, C.H
Wang, T.N
Wang, K.Y
Wang, W.M
Author_xml – sequence: 1
  fullname: Wang, K.Y
– sequence: 2
  fullname: Li, S.N
– sequence: 3
  fullname: Liu, C.S
– sequence: 4
  fullname: Perng, D.S
– sequence: 5
  fullname: Su, Y.C
– sequence: 6
  fullname: Wu, D.C
– sequence: 7
  fullname: Jan, C.M
– sequence: 8
  fullname: Lai, C.H
– sequence: 9
  fullname: Wang, T.N
– sequence: 10
  fullname: Wang, W.M
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16071354$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15321816$$D View this record in MEDLINE/PubMed
BookMark eNqF0M-PEyEUB3Bi1rjd1aNXJSZ6m-4DBgaOutkfJk086J4nQKHSUKgwE61_vdStMfHiBQj5vAfve4HOUk4OoZcElgQUu9Jbm64kLNlyYMMTtCCKyY5RGM7QAgBop4jg5-ii1i0Aob0Uz9A54YwSScQC_bjx3tmp4uxxSBtXp7bilbZTNtqGGOfaYZ3W-EPwYX28m1wJ866zOU06pKM-5M1cplaO62y2v7t9D9NXbHPMKfx0a3zvYrCnYrw_xFzCc_TU61jdi9N-iR5ub75c33erT3cfr9-vOs-ImrqecSE4l2DaiQsnDQVKiRh6Kwk4bqQxnhgFjilqqDTKMM-Mt0QLA3xgl-jdY999yd_mNt-4C9W6GHVyea6jEBJaHPy_sFfHaKFv8M0_cJvnktoQI21_ZkoJ2tCrE5rNzq3HfQk7XQ7jn-QbeHsCulodfdHJhvrXCRgI48fXXj86r_OoN6WZh88UCANQ_dAiYb8AB5edqA
CODEN AJCNAC
ContentType Journal Article
Copyright 2004 INIST-CNRS
Copyright American Society for Clinical Nutrition, Inc. Sep 2004
Copyright_xml – notice: 2004 INIST-CNRS
– notice: Copyright American Society for Clinical Nutrition, Inc. Sep 2004
DBID FBQ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T7
7TS
8FD
C1K
FR3
K9.
NAPCQ
P64
7S9
L.6
7X8
DOI 10.1093/ajcn/80.3.737
DatabaseName AGRIS
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Physical Education Index
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Nursing & Allied Health Premium

MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1938-3207
EndPage 741
ExternalDocumentID 713206731
15321816
16071354
US201300947556
Genre Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-ET
-~X
..I
.55
.GJ
0R~
1HT
23M
2FS
2WC
3O-
4.4
48X
53G
5GY
5RE
5VS
6J9
85S
8R4
8R5
AABZA
AACZT
AAGQS
AAHBH
AAIKC
AAJQQ
AAMNW
AAPGJ
AAPQZ
AAUQX
AAUTI
AAVAP
AAWDT
AAWTL
AAXUO
AAYOK
ABBTP
ABDNZ
ABDPE
ABIME
ABJNI
ABLJU
ABOCM
ABPTD
ABWST
ACFRR
ACGFO
ACGFS
ACGOD
ACNCT
ACPRK
ACPVT
ACUFI
ACUTJ
ADBBV
ADGZP
ADHUB
ADMTO
ADRTK
ADUKH
ADVEK
ADVLN
AEGXH
AENEX
AETBJ
AFFDN
AFFNX
AFFZL
AFJKZ
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGNAY
AGQXC
AGUTN
AHMBA
AI.
AIAGR
AITUG
AJEEA
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANFBD
AQDSO
AQKUS
BAWUL
BAYMD
BKOMP
BTRTY
C1A
CDBKE
DAKXR
DIK
E3Z
EBS
EIHJH
EJD
ENERS
EX3
F5P
F9R
FBQ
FDB
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
FRP
GAUVT
GJXCC
GX1
H13
HF~
HZ~
IH2
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
LPU
MBLQV
MHKGH
MV1
MVM
N4W
NEJ
NHB
NHCRO
NOMLY
NOYVH
NVLIB
O9-
ODMLO
OHT
OK1
OVD
P2P
P6G
PCD
PQQKQ
PRG
Q2X
R0Z
RHI
RNS
ROL
SJN
TCN
TEORI
TMA
TNT
TR2
TWZ
UBH
UHB
UKR
VH1
W2D
W8F
WH7
WHG
WOQ
WOW
X7M
XOL
XSW
YBU
YHG
YOJ
YQJ
YR5
YRY
YSK
YV5
YYQ
YZZ
ZCA
ZCG
ZGI
ZUP
ZXP
~KM
AALRI
AAYWO
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AIGII
AKBMS
AKYEP
APXCP
EFKBS
IQODW
NU-
A8Z
ABSAR
BCRHZ
CGR
CUY
CVF
ECM
EIF
NPM
RHF
ROX
SV3
VXZ
Z5M
7QP
7T7
7TS
8FD
C1K
FR3
K9.
NAPCQ
P64
7S9
L.6
7X8
ID FETCH-LOGICAL-f319t-435665580b43556e8b20221674c810e5b8bbf1b90e392b28b9b3f3bfc1a6b0573
ISSN 0002-9165
IngestDate Thu Jul 10 23:49:37 EDT 2025
Mon Jul 21 09:44:18 EDT 2025
Fri Jul 25 05:04:13 EDT 2025
Wed Feb 19 02:24:36 EST 2025
Mon Jul 21 09:16:20 EDT 2025
Thu Apr 03 09:46:48 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Human
Probiotic
Bifidobacterium
Actinomycetaceae
Spirillales
Lactobacillus acidophilus La5
Spirillaceae
Yogurt
Lactobacillus acidophilus
Actinomycetales
Urea
Probiotics
Breath test
Helicobacter pylori
Bifidobacterium lactis Bb12
Bacteria
Lactobacillaceae
Actinomycetes
urea breath test
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-f319t-435665580b43556e8b20221674c810e5b8bbf1b90e392b28b9b3f3bfc1a6b0573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Undefined-3
PMID 15321816
PQID 231939962
PQPubID 41076
PageCount 5
ParticipantIDs proquest_miscellaneous_66801535
proquest_miscellaneous_49193804
proquest_journals_231939962
pubmed_primary_15321816
pascalfrancis_primary_16071354
fao_agris_US201300947556
PublicationCentury 2000
PublicationDate 2004-09-01
PublicationDateYYYYMMDD 2004-09-01
PublicationDate_xml – month: 09
  year: 2004
  text: 2004-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
– name: Bethesda
PublicationTitle The American journal of clinical nutrition
PublicationTitleAlternate Am J Clin Nutr
PublicationYear 2004
Publisher American Society for Clinical Nutrition
American Society for Clinical Nutrition, Inc
Publisher_xml – name: American Society for Clinical Nutrition
– name: American Society for Clinical Nutrition, Inc
References 15817875 - Am J Clin Nutr. 2005 Apr;81(4):939; aithor reply 939-40
References_xml – reference: 15817875 - Am J Clin Nutr. 2005 Apr;81(4):939; aithor reply 939-40
SSID ssj0012486
Score 2.2807608
Snippet Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans....
Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing...
SourceID proquest
pubmed
pascalfrancis
fao
SourceType Aggregation Database
Index Database
Publisher
StartPage 737
SubjectTerms Adult
Antibiosis
Bacteria
Bifidobacterium
Bifidobacterium - physiology
Bifidobacterium animalis
Biological and medical sciences
Breath Tests
Carbon Isotopes
Colony Count, Microbial
diagnostic use
Feeding. Feeding behavior
Female
Food Microbiology
Fundamental and applied biological sciences. Psychology
growth & development
Helicobacter Infections
Helicobacter Infections - microbiology
Helicobacter Infections - prevention & control
Helicobacter pylori
Helicobacter pylori - growth & development
Humans
Infections
lactic acid bacteria
Lactobacillus
Lactobacillus - physiology
Lactobacillus acidophilus
Lactobacillus acidophilus - physiology
Male
microbial load
microbiology
Middle Aged
milk
mixed culture
physiology
placebos
prevention & control
Probiotics
therapeutics
Treatment Outcome
urease
Vertebrates: anatomy and physiology, studies on body, several organs or systems
viability
volunteers
Yogurt
Yogurt - microbiology
Title Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori
URI https://www.ncbi.nlm.nih.gov/pubmed/15321816
https://www.proquest.com/docview/231939962
https://www.proquest.com/docview/49193804
https://www.proquest.com/docview/66801535
Volume 80
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCMZlYTD8gHiZ3KVJnCaPQIfGZRVSW2k8RbHjdJm6pGpiwfY3-MMcx85lg0rASxTZjh3lfDn-jn18DkKvYYoQibDHhLlcEI-nHgkZd4nvJoz7YyelXC0NnE79k4X36YyeDQY_e15LsmJDfv3HcyX_I1UoA7mqU7L_INm2UyiAe5AvXEHCcP0rGR93zhhqda6sXZi_qAw6LObZaiVLUm8OvMvSLFFlKjCzvCTKP11nhji8KpZyU6cJKCW7qHsz3ugr-NuvgY7CxARo0Q8frpV9n_UZ7bw7mpL341C0Ry7zJt5_t3Zv9IuMc_JN9pyCas-C2bnMyDTrlUrtFwBAXpLZeVfzVWx0T5P4O1RcFWYWbhYxvNZLq6-YganSvmLWKZ4MAN2elh3rODG_aX8dGSu-4GqGC-yhO7zVEsS3vqzBAIpekZtbUbi1WWSq7qC7DtgeKi3G5OPndmvK8er0oe0bm8CtMPaRGvmoGbdO-KR7At6SxoVyu41L-PCpTpmy3aapuc38IXpgjBL8ViPsERqIfBdZk0xU-A02kWNXeNoIchfdOzUuGY_RDwNCXKS4BSG-CUIMIMTbQYg1COFx3IAQKxDiFoS4D0KsQfgELT4cz9-fEJPOg6Sg5ysCxNz3KQ1sBnfUFwFzgECqUzA8GNmCsoCxdMRCWwBnZ07AQuamLkv5KPaZitv5FO3kRS72EBZJAqa3I0bMFZ4b85CGYZAIjydjxlMeWmgPPngUL2GijBYzR23P26E3hmEtdHBDCtFaR3WJ6kiLLvUstN-IJTJ_TRmBFRQClfcdC71qa0ERq921OBeFLCMvhCaB7W1v4ftAB6lLLfRMS7sb2wDl-daafXS_-29eoJ1qI8VLoMMVO6jh-QvXS7gk
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+ingesting+Lactobacillus-+and+Bifidobacterium-containing+yogurt+in+subjects+with+colonized+Helicobacter+pylori&rft.jtitle=The+American+journal+of+clinical+nutrition&rft.au=Wang%2C+Kuan-Yuan&rft.au=Li%2C+Shui-Nin&rft.au=Liu%2C+Chiang-Shin&rft.au=Perng%2C+Daw-Shyong&rft.date=2004-09-01&rft.issn=0002-9165&rft.volume=80&rft.issue=3&rft.spage=737&rft_id=info:doi/10.1093%2Fajcn%2F80.3.737&rft_id=info%3Apmid%2F15321816&rft.externalDocID=15321816
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9165&client=summon